Culture Diffusion Chambers

Devices used in a technique by which cells or tissues are grown in vitro or, by implantation, in vivo within chambers permeable to diffusion of solutes across the chamber walls. The chambers are used for studies of drug effects, osmotic responses, cytogenic and immunologic phenomena, metabolism, etc., and include tissue cages.

Also Known As:

Diffusion Chambers, Culture; Semipermeable Chambers; Cage, Tissue; Cages, Tissue; Chamber, Culture Diffusion; Chamber, Semi-Permeable; Chamber, Semipermeable; Chambers, Culture Diffusion; Chambers, Semi-Permeable; Chambers, Semipermeable; Culture Diffusion Chamber; Diffusion Chamber, Culture; Semi Permeable Chambers; Semi-Permeable Chamber; Semipermeable Chamber; Tissue Cage; Semi-Permeable Chambers; Tissue Cages

Networked: 130 relevant articles (14 outcomes, 17 trials/studies)

Relationship Network

Therapy Context: Research Results

Equipment and Supplies
- Culture Diffusion Chambers: 130

Experts

1.	Lees, P: 12 articles (08/2014 - 01/2001)
2.	Lew, Daniel P: 7 articles (07/2009 - 05/2002)
3.	Vaudaux, Pierre: 7 articles (07/2009 - 05/2002)
4.	Ding, Huanzhong: 6 articles (01/2022 - 07/2015)
5.	Murillo, Oscar: 6 articles (06/2018 - 03/2009)
6.	Landoni, M F: 6 articles (08/2011 - 01/2001)
7.	Shen, Xiangguang: 5 articles (01/2022 - 07/2015)
8.	Zhang, Longfei: 5 articles (01/2019 - 07/2015)
9.	Ariza, Javier: 5 articles (06/2018 - 03/2009)
10.	El Haj, Cristina: 5 articles (06/2018 - 09/2014)

Related Diseases

1.	Infections 12/01/1984 - "The tissue cage model offers a suitable way for studies of the pathogenesis of GBS infection. " 04/01/1984 - "The properties of tissue cage fluid and the possibility of repeated sampling make the model suitable for studies of experimental local infections. " 03/22/2023 - "A Galleria mellonella model and a rat tissue cage infection model were established to assess in vivo synergistic effects. " 01/01/2023 - "multocida) was evaluated by establishing a piglet tissue cage infection model. " 01/01/2021 - "A tissue-cage infection model of rats was established to evaluate in vivo synergistic effects. "
2.	Foreign Bodies (Foreign Body) 10/01/1982 - "An animal model involving the subcutaneous implantation of tissue cages into guinea pigs and subsequent infection with Staphylococcus aureus was used for study factors pertinent to foreign body infection. " 08/21/2014 - "Applications of the tissue cage and catheter abscess foreign body infection models in the mouse will be discussed herein. " 04/01/2006 - "These include experimental pneumonia in mice, a tissue cage model of foreign body infection in rats, and endocarditis models in rats and rabbits. " 11/01/2009 - "We aimed to quantify the presence of intracellular Staphylococcus aureus and to study the extent to which the intracellular activity of antibiotics might determine their efficacy against an experimental rat tissue-cage model of foreign-body infection. " 12/01/1990 - "A novel model of experimental foreign body infection was developed in rats: four perforated Teflon tissue cages per animal were implanted subcutaneously and 3 to 4 weeks later were infected with 0.5 x 10(5) to 2 x 10(5) CFU of methicillin-resistant Staphylococcus aureus. "
3.	Body Weight (Weight, Body) 03/01/2021 - "Tissue Cage (TC) model was used to evaluate the pharmacokinetics and ex vivo pharmacodynamics of Minocycline (MINO) after intramuscular (IM) administration to donkeys at 4 mg/kg body-weight. " 01/01/2019 - "aureus was injected into the tissue cages at 1010 colony forming units (CFU)/mL. We injected different intramuscular concentrations of amoxicillin at doses of 5, 10, 20, and 30 mg/kg body weight once a day for 5 days and 5, 10, 20, and 30 mg/kg body weight twice a day for 2.5 days. " 01/01/2018 - "In a rat tissue cage model, we evaluated the efficacy of adjunctive gentamicin (GEN) administered systemically (5 mg/kg body weight) every 24 h, or locally (12.5 mg/L tissue cage concentration) every 24 or 72 h, in combination with penicillin (PEN) administered systemically (250,000 IU/kg body weight three times per day). " 02/01/1993 - "Cefazolin or cefmetazole (100 mg/kg of body weight every 8 h for 8 days) was administered to rabbits with infected tissue cages. " 05/01/2002 - "A single dose of 50 mg of levofloxacin per kg of body weight, administered intraperitoneally 3 h before bacterial challenge, was more efficient than vancomycin for the prevention of infections in tissue cages with MRSA inocula of 10(4) and 10(5) CFU. "
4.	Streptococcal Infections (Streptococcal Infection) 11/01/1988 - "Tissue cages for study of experimental streptococcal infection in rabbits. " 03/01/1985 - "Tissue cages for study of experimental streptococcal infection in rabbits. " 01/01/1982 - "Tissue cages for study of experimental streptococcal infection in rabbits. "
5.	Inflammation (Inflammations) 06/01/2012 - "Development and validation of a tissue cage model of acute inflammation in the cat." 04/01/2003 - "The pharmacokinetics and pharmacodynamics of KTP were investigated using a tissue cage model of acute inflammation. " 01/01/2001 - "A tissue cage model of inflammation was used. " 12/01/1999 - "Each enantiomer was administered separately (1.5 mg/kg) and in a racemic mixture (3 mg/kg) intravenously (i.v.) to a group of eight sheep in a four-way, four-period cross-over study using a tissue cage model of inflammation. " 08/01/2013 - "A tissue cage model of inflammation in calves was used to determine the pharmacokinetic and pharmacodynamic properties of individual carprofen enantiomers, following the administration of the racemate. "

Related Drugs and Biologics

1.	Rifampin (Rifampicin)
2.	Vancomycin
3.	Levofloxacin (Levaquin)
4.	Daptomycin
5.	Cloxacillin (Tegopen)
6.	Methicillin (Metin)
7.	Anti-Bacterial Agents (Antibiotics)
8.	cefquinome
9.	Penicillins (Penicillin)
10.	Zidovudine (Retrovir)

Related Therapies and Procedures

1.	Therapeutics
2.	Injections
3.	Culture Diffusion Chambers
4.	Intravenous Administration
5.	Catheters